In HER2 positive patients, our TCGA analysis confirmed that high MARCKS expression was significantly associated with HER2 positivity, ER and PR negativity, higher tumor mutational burden, and younger age at diagnosis. This evidence concerns the gene MARCKS and neoplasm.